Thyroid Eye Disease (TED) Coding in 2026: A New Era of Diagnostic Precision

Thyroid Eye Disease (TED) has long posed both clinical and coding challenges due to its complex presentation and historical lack of diagnostic specificity. With the introduction of new ICD-10-CM codes effective October 1, 2025, providers and coders now have a powerful opportunity to improve documentation accuracy, patient identification, and reimbursement outcomes.

This update marks a significant shift in how TED is captured across the healthcare ecosystem—impacting everything from clinical care pathways to population health data.

Understanding Thyroid Eye Disease: More Than an Ocular Condition

TED—also referred to as Graves’ ophthalmopathy or Graves’ orbitopathy—is a chronic autoimmune inflammatory disorder affecting the orbit. While it is most commonly associated with hyperthyroidism (particularly Graves’ disease), it can also occur in euthyroid or hypothyroid patients.

Common Clinical Manifestations

TED presents with a spectrum of symptoms that can range from mild irritation to severe, vision-threatening complications:

• Ocular dryness and irritation
• Conjunctival redness and inflammation
• Periorbital edema (swelling around the eyes)
• Eyelid retraction
• Proptosis (eye bulging)
• Diplopia (double vision)
• Exposure keratopathy
• Optic nerve compression (in advanced cases)

The variability in presentation makes early recognition and accurate documentation critical—not just for treatment, but also for coding integrity.

Diagnostic Approach: Supporting Accurate Code Assignment

A confirmed diagnosis of TED is typically based on a combination of clinical findings, laboratory results, and imaging studies.

Key Diagnostic Components

• Thyroid function tests (TSH, T3, T4 levels)
• Autoantibody testing (e.g., TSH receptor antibodies)
• Orbital imaging (CT or MRI to assess muscle enlargement and orbital involvement)
• Clinical Activity Score (CAS) to evaluate inflammatory activity
• Severity classification systems (mild, moderate-to-severe, sight-threatening)

For coders, detailed provider documentation of laterality, severity, and associated systemic conditions is essential to ensure precise code selection.

Treatment Landscape: From Symptom Control to Advanced Therapies

Management of TED depends on disease severity and activity phase (active vs. inactive).

Treatment Modalities Include:

• Supportive care: Artificial tears, lubricating ointments
• Medical therapy:
  • Corticosteroids (oral or IV)
  • Immunosuppressive agents
• Biologic therapy: Targeted treatments such as IGF-1 receptor inhibitors have transformed care for moderate-to-severe TED
• Surgical intervention:
  • Orbital decompression
  • Strabismus correction
  • Eyelid repositioning

Accurate coding must reflect not only the diagnosis but also the complexity of care delivered.

ICD-10-CM Update: New TED Codes (Effective October 1, 2025)

Prior to this update, TED was typically reported using H05.89 (Other disorders of orbit)—a non-specific code that limited clinical clarity and data accuracy.

New Dedicated TED Codes

The 2026 ICD-10-CM update introduces a new category:

H05.83 – Thyroid orbitopathy

• H05.831 – Right orbit
• H05.832 – Left orbit
• H05.833 – Bilateral
• H05.839 – Unspecified orbit

Why This Matters

These new codes allow for:

• Precise identification of TED cases
• Improved tracking of disease prevalence and outcomes
• Enhanced payer communication and reduced claim ambiguity
• Better alignment with clinical documentation

Coding Best Practices for TED

To fully leverage the new coding structure, coders and providers must work in tandem to ensure documentation completeness.

1. Capture Laterality

Always code to the highest level of specificity. If documentation supports it, avoid using unspecified codes.

2. Report Associated Thyroid Conditions

TED is often linked to underlying thyroid disorders. Use additional codes when applicable:

• E05.0- – Thyrotoxicosis with diffuse goiter (Graves’ disease)
• E06.3 – Autoimmune thyroiditis

3. Align Terminology with Coding Language

Providers may document:

• Thyroid Eye Disease (TED)
• Graves’ ophthalmopathy
• Graves’ orbitopathy

All of these map to thyroid orbitopathy (H05.83-), but coders should ensure documentation clearly supports the diagnosis.

4. Reflect Disease Severity When Documented

While ICD-10 does not yet differentiate TED severity within this code set, documenting severity supports medical necessity and downstream care decisions.

5. Avoid Legacy Coding Habits

Discontinue use of H05.89 for TED unless documentation truly lacks specificity.

The Bigger Picture: Why Accurate TED Coding Matters

Historically, the absence of a dedicated TED code has led to inconsistent reporting and unreliable epidemiological data. Estimates have varied widely, with studies suggesting:

• 21 to 90 cases per 100,000 individuals
• 25% to 50% of patients with Graves’ disease developing TED

This variability underscores the importance of standardized coding.

Impact of the New Codes

• Improved Data Integrity: Enables more reliable prevalence and incidence tracking
• Enhanced Research Opportunities: Supports clinical studies and treatment innovation
• Better Patient Stratification: Helps identify high-risk populations
• Stronger Reimbursement Justification: Reduces payer ambiguity and denials

Accurate coding is no longer just an administrative task—it’s a clinical and financial imperative.

Final Thoughts

The introduction of dedicated ICD-10-CM codes for Thyroid Eye Disease represents a pivotal advancement in both clinical documentation and revenue cycle management. By embracing these changes and prioritizing detailed, accurate coding practices, healthcare organizations can improve patient outcomes, strengthen compliance, and unlock more reliable healthcare data.

Optimize Your Ophthalmology Revenue Cycle with Expert TED Coding Support

As coding requirements evolve, especially with the introduction of new, highly specific ICD-10-CM codes for conditions like Thyroid Eye Disease, ophthalmology practices must stay ahead to avoid costly errors, denials, and missed revenue opportunities.

At Bristol Healthcare Services, we specialize in delivering end-to-end ophthalmology billing services and ophthalmology coding services designed to keep your practice compliant, efficient, and financially optimized. Our certified coding experts stay up to date with the latest coding changes—including nuanced updates like TED-specific codes—ensuring every diagnosis is captured with precision and every claim is submitted accurately the first time.

From detailed chart audits and coding reviews to denial management and AR follow-ups, our tailored solutions help ophthalmology practices:

• Improve coding accuracy and documentation integrity
• Reduce claim denials and accelerate reimbursements
• Ensure full compliance with evolving payer and regulatory requirements
• Gain actionable insights through advanced reporting and analytics

With a proven track record of delivering measurable results, we empower your practice to focus on what matters most—delivering exceptional patient care—while we handle the complexities of your revenue cycle.